PharmaCyte Biotech Inc (NASDAQ:PMCB)

2.21
BATS BZX Real-Time Price
As of 11:37am ET
 -0.05 / -2.21%
Today’s Change
1.79
Today|||52-Week Range
21.00
-11.60%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
--

Company Description

PharmaCyte Biotech, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of treatments for cancer and diabetes. It focuses on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box, which will be used as a platform for the development of treatments for inoperable pancreatic cancer and other solid cancerous tumors, and diabetes. The company was founded on October 28, 1996 and is headquartered in Laguna Hills, CA.

Contact Information

PharmaCyte Biotech, Inc.
23046 Avenida de la Carlota
Laguna Hills California 92653
P:(917) 595-2850
Investor Relations:

Employees

Shareholders

Mutual fund holders3.97%
Other institutional20.33%
Individual stakeholders0.24%

Top Executives

Kenneth L. WaggonerChairman, President, CEO & Secretary
Carlos A. TrujilloChief Financial Officer & Director
José L. IglesiasChief Medical Officer
Gerald W. CrabtreeDirector & Chief Scientific Officer
Lilli BrandtnerDirector-Diabetes Program Development